(Total Views: 605)
Posted On: 01/09/2023 8:56:10 AM
Post# of 22465
Re: SwampAngel #21959
Here is a new stock investment called interestingly QSI Quantum!
QUANTUM-SI.COM
QUANTUM-SI.COM/PRODUCTS/
Quick run up to their 1/9 pr!
Quantum-Si announces that management will discuss the following business updates at the 41st Annual J.P. Morgan Healthcare Conference
8:04 AM ET 1/9/23 | Briefing.com
Quantum-Si has begun commercial shipments of the Platinum protein sequencing system.The Company announced a partnership with Aviva Systems Biology, a leading provider of antibody, protein, and immunoassay reagent products, to co-develop sample preparation kits for protein sequencing research workflows with Platinum.Quantum-Si announced a partnership and license agreement with Biovista, an AI-driven bioscience firm, to integrate Biovista's database and visualization technology into Quantum-Si's Cloud analytics to advance proteomics research, biomarker discovery, and drug development applications.The Company reaffirms commitment to fiscal discipline and seeks to extend cash runway beyond the current guidance of 2024.
$5-$10+
QUANTUM-SI.COM
QUANTUM-SI.COM/PRODUCTS/
Quick run up to their 1/9 pr!
Quantum-Si announces that management will discuss the following business updates at the 41st Annual J.P. Morgan Healthcare Conference
8:04 AM ET 1/9/23 | Briefing.com
Quantum-Si has begun commercial shipments of the Platinum protein sequencing system.The Company announced a partnership with Aviva Systems Biology, a leading provider of antibody, protein, and immunoassay reagent products, to co-develop sample preparation kits for protein sequencing research workflows with Platinum.Quantum-Si announced a partnership and license agreement with Biovista, an AI-driven bioscience firm, to integrate Biovista's database and visualization technology into Quantum-Si's Cloud analytics to advance proteomics research, biomarker discovery, and drug development applications.The Company reaffirms commitment to fiscal discipline and seeks to extend cash runway beyond the current guidance of 2024.
$5-$10+
(0)
(0)
